Discontinued — last reported Q4 '21
Geographic · Property, plant, and equipment, net
Europe — Property, plant, and equipment, net
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ4 2021
Rolls up toProperty, plant and equipment, net
How to read this metric
An increase suggests capital expansion or investment in regional infrastructure, while a decrease may indicate asset depreciation, divestiture, or a shift in the regional manufacturing footprint.
Detailed definition
This metric represents the net book value of tangible long-term assets, such as manufacturing facilities, laboratories,...
Peer comparison
Peers in the pharmaceutical industry typically report this as part of their regional segment disclosures, with levels varying based on whether the company maintains internal manufacturing capacity or relies on third-party contract manufacturers in that region.
Metric ID:
regn_segment_europe_property_plant_and_equipment_netHistorical Data
1 periods
| Q4 '21 | |
|---|---|
| Value | $797.80M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's europe — property, plant, and equipment, net?
- Regeneron Pharmaceuticals (REGN) reported europe — property, plant, and equipment, net of $797.80M in Q4 2021.
- What does europe — property, plant, and equipment, net mean?
- The net value of the company's physical assets, such as buildings and machinery, located in Europe.